Tianlong Science and Technology

Tianlong Science and Technology, founded in 1997, is a leading Chinese national high-tech enterprise specializing in molecular diagnostics and in vitro diagnostics. The company develops and manufactures a comprehensive range of nucleic acid detection instruments and compatible reagents, leveraging advanced platforms such as PCR, gene chip, sequencing, RMT, and CRISPR-based detection. Their products cater to diverse applications including clinical diagnostics, infectious disease control, genetic testing, food safety, and scientific research, addressing indications like infectious diseases, genetic disorders, and oncology. Tianlong has achieved over 70 China NMPA approvals and more than 120 international certifications, distributing its products to over 100 countries. It was acquired by Shanghai Kehua Bio-Engineering Co., Ltd. (KHB).